Public COA audit

BPC-157 · Thymosin Beta-4

Audited July 28, 2026

Evidence suggests fabrication

Multiple signals on this document conflict with known lab formats or verification patterns.

Legitimacy
15
Confidence
92%
Panels
3/7
Purity (printed)
99.393%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
BPTB20-032026-1
Identity method
HPLC with UV Detection Coupled with Mass Spectrometry
Issue date
2026-03-21

7-panel checklist

Standard peptide COA panels PeptIQ checks for on each document.

  • Identity

    Compound identity confirmed (e.g. HPLC, mass spec).

    BPC-157/Thymosin Beta-4

    Result: pass

  • Purity

    Reported purity percentage for the analyte.

    99.393%

    Result: pass

  • Heavy metals

    Lead, arsenic, cadmium, mercury, or similar limits.

  • Microbial

    Bioburden / microbial limits testing.

  • Endotoxin

    LAL or chromogenic endotoxin assay.

    Replicate 1: PASS, Replicate 2: PASS

    Result: pass

  • Sterility

    Sterility testing where applicable.

  • Residual solvent / water

    Residual solvents or water content limits.

Findings

Evidence-linked observations from this audit.

  • Future dates

    Received date 03/19/2026 and reported date 03/21/2026 are in the future, indicating this document was fabricated or backdated

  • Unverifiable laboratory

    Freedom Diagnostics does not appear to be a recognized peptide testing laboratory. The website FreedomDiagnosticsTesting.com and contact [email protected] cannot be independently verified as legitimate analytical testing facilities

  • Non-standard COA format

    Document layout and presentation quality appear inconsistent with professional analytical laboratory standards. Generic branding and minimal laboratory accreditation information

  • Suspicious lot number pattern

    Lot number BPTB20-032026-1 contains the future date 032026, suggesting fabrication rather than authentic batch tracking

  • Unusually high purity claim

    99.393% purity for a dual-peptide blend is exceptionally high and presented without supporting chromatogram detail or method validation

  • Mass spec data lacks detail

    Mass identification chart shows peaks but lacks proper axis labels, resolution details, or comprehensive spectral data expected from LCMS/MS analysis

  • Missing critical safety panels

    No heavy metals, microbial contamination, sterility, or residual solvent testing reported, which are standard for peptide COAs

  • No accreditation information

    Document lacks ISO 17025, GMP, or other laboratory accreditation credentials that legitimate testing facilities display

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.